|

Sacubitril-valsartan in Patients With Heart Failure.

RECRUITINGN/ASponsored by Damanhour University
Actively Recruiting
PhaseN/A
SponsorDamanhour University
Started2025-08-01
Est. completion2026-03-01
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07341893

Summary

The aim of this study is to evaluate the safety and efficacy of Sacubitril -Valsartan in patients with heart failure.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age ≥ 18 years old for both genders.
* LV ejection fraction (LVEF) ≤40%.
* Heart failure patients with NYHA grade II-IV.

Exclusion Criteria:

1. CKD with GFR \< 20 ml/min/1.73
2. Serum potassium \< 5.5 mmol / L.
3. Pregnant or lactating women
4. Active infection.
5. Congenital heart disease.
6. Autoimmune disorders or connective tissue disorders.
7. Severe hepatic dysfunction.

Conditions2

Heart DiseaseHeart Failure

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.